[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555995":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":30,"responsibleParty":64,"collaborators":20,"id":66,"slug":67,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":68,"sex":74,"minAge":75,"maxAge":20,"enrollmentInfo":76,"targetDuration":20,"studyType":79,"phases":80,"briefSummary":82,"conditions":83,"keywords":85,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Echosens","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Adult patient (age >= 18 y.o) followed for a liver disease, all etiologies combined","EXPERIMENTAL","Adult patients followed in the Hepatology or Endocrinology department for a liver disease, suspected chronic liver disease or consequences of chronic liver disease, all etiologies combined.",[13],"Device: Research FibroScan (FS)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Research FibroScan (FS)","Patients #1 to #25:\n\nExam 1: Examination with Research FibroScan. Exam 2: Examination with the Reference FibroScan at the same measurement point and with the same probe used for the Exam 1.\n\nPatients #26 to #75:\n\nExam 1: Examination with the Research or Reference FibroScan. Exam 2: Examination with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exam 1.\n\nPatients #76 to #114:\n\nExams 1 \\& 2: 2 consecutive examinations with the Research or Reference FibroScan.\n\nExams 3 \\& 4: 2 consecutive examinations with the Reference or Research FibroScan at the same measurement point and with the same probe used for the Exams 1 \\& 2.",[9],null,[22,27],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Anne Llorca","CONTACT","+33144827850","anne.llorca@echosens.com",{"name":28,"role":24,"phone":25,"phoneExt":20,"email":29},"Laura Cantu-Sanchez","laura.cantusanchez@echosens.com",[31,49],{"facility":32,"status":33,"city":34,"state":20,"zip":35,"country":36,"countryCode":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"Groupe Hospitalier Nord Essonne - Site Paris- Saclay","RECRUITING","Orsay","91400","France","FR",{"type":39,"coordinates":40},"Point",[41,42],2.18727,48.69572,{"lat":42,"lon":41},[45],{"name":46,"role":24,"phone":47,"phoneExt":20,"email":48},"Edoardo Poli, Dr","+33 1 69 15 91 01","e.poli@gh-nord-essonne.fr",{"facility":50,"status":33,"city":51,"state":52,"zip":53,"country":36,"countryCode":37,"cosmosGeoPoint":54,"geoPoint":58,"contacts":59},"Hôpital Pitié-Salpêtrière","Paris","Île-de-France Region","75013",{"type":39,"coordinates":55},[56,57],2.3488,48.85341,{"lat":57,"lon":56},[60],{"name":61,"role":24,"phone":62,"phoneExt":20,"email":63},"Vlad Ratziu, Pr","+33 1 42 17 76 22","vlad.ratziu@inserm.fr",{"type":65,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100555995","development-of-a-new-method-for-liver-stiffness-measurement-using-fibroscan-100555995",false,"NCT06519331","Development of a New Method for Liver Stiffness Measurement Using FibroScan","M148 - Development of a New Method for Liver Stiffness Measurement Using FibroScan","M148","Inclusion Criteria:\n\n* Adult patients (≥ 18 years of age) followed in the hepatology or endocrinology department for liver disease, suspected liver disease or consequences of liver disease, all etiologies combined.\n* Adult patient able to give his written consent\n* Patient affiliated to the French Social Security system\n\nExclusion Criteria:\n\n* Vulnerable patients\n* Patients with liver ascites\n* Patients with heart failure","ALL","18 Years",{"count":77,"type":78},114,"ESTIMATED","INTERVENTIONAL",[81],"NA","This is an European, prospective, interventional, multicenter clinical investigation that will take place in 2 French sites. 114 adults patients will be included. The study objective is to develop a new method for measuring liver stiffness using FibroScan.",[84],"Liver Diseases",[86,87,88],"FibroScan","Vibration Controlled Transient Elastography","Liver Stiffness Measurement","2025-08-11",{"date":91,"type":92},"2025-08-14","ACTUAL",{"date":94,"type":92},"2024-11-08",{"date":96,"type":78},"2027-05-31",{"name":5,"class":6},2]